Jerzy Gumulka
Director/Board Member bei CNS PHARMACEUTICALS, INC.
Vermögen: 15 568 $ am 31.03.2024
Profil
Jerzy Gumulka is an Independent Director at CNS Pharmaceuticals, Inc. since 2017.
He was a Director at Moleculin LLC from 2010 to 2016.
Prior to that, he was a Technical Director at Kraton Polymers do Brasil SA from 2001 to 2015 and a Technology Manager at Kraton Polymers U.S.
LLC from 2001 to 2016.
Dr. Gumulka holds a doctorate degree from the University of Warsaw.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 08.04.2024 | 43 006 ( 0,51% ) | 15 568 $ | 31.03.2024 |
Aktive Positionen von Jerzy Gumulka
| Unternehmen | Position | Beginn |
|---|---|---|
| CNS PHARMACEUTICALS, INC. | Director/Board Member | 08.11.2017 |
Ehemalige bekannte Positionen von Jerzy Gumulka
| Unternehmen | Position | Ende |
|---|---|---|
Kraton Polymers U.S. LLC
 Kraton Polymers U.S. LLC Chemicals: Major DiversifiedProcess Industries Kraton Polymers U.S. LLC engages in the manufacture of chemicals and adhesives. The company is headquartered in Houston, TX. | Chief Tech/Sci/R&D Officer | 01.06.2016 |
Moleculin LLC
 Moleculin LLC Pharmaceuticals: MajorHealth Technology Moleculin LLC develops dermatological products for treatment of skin disorders. The company was founded by Klemp V. Walter in 2006 and is headquartered in Houston, TX. | Director/Board Member | 01.01.2016 |
Kraton Polymers do Brasil SA
 Kraton Polymers do Brasil SA Miscellaneous ManufacturingProducer Manufacturing Part of DL Holdings Co., Ltd., Kraton Polymers do Brasil SA is a leading producer of styrenic block copolymers, specialty polymers, and high-value performance products derived from pine wood pulping co-products. The private company is based in São Paulo, Brazil. The Brazilian company conducts security vulnerability assessments at all sites and has been a preferred bitumen modifier for roofing products since the 1980s. In the 2000s, their bitumen modification with Kraton D polymers has delivered improved durability and resistance to rutting and low-temperature cracking. | Chief Tech/Sci/R&D Officer | 01.01.2015 |
Ausbildung von Jerzy Gumulka
| University of Warsaw | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| CNS PHARMACEUTICALS, INC. | Health Technology |
| Private Unternehmen | 3 |
|---|---|
Moleculin LLC
Moleculin LLC Pharmaceuticals: MajorHealth Technology Moleculin LLC develops dermatological products for treatment of skin disorders. The company was founded by Klemp V. Walter in 2006 and is headquartered in Houston, TX. | Health Technology |
Kraton Polymers do Brasil SA
Kraton Polymers do Brasil SA Miscellaneous ManufacturingProducer Manufacturing Part of DL Holdings Co., Ltd., Kraton Polymers do Brasil SA is a leading producer of styrenic block copolymers, specialty polymers, and high-value performance products derived from pine wood pulping co-products. The private company is based in São Paulo, Brazil. The Brazilian company conducts security vulnerability assessments at all sites and has been a preferred bitumen modifier for roofing products since the 1980s. In the 2000s, their bitumen modification with Kraton D polymers has delivered improved durability and resistance to rutting and low-temperature cracking. | Producer Manufacturing |
Kraton Polymers U.S. LLC
Kraton Polymers U.S. LLC Chemicals: Major DiversifiedProcess Industries Kraton Polymers U.S. LLC engages in the manufacture of chemicals and adhesives. The company is headquartered in Houston, TX. | Process Industries |
